ACP 2025: Collaborative care can help address the mental health crisis, but payment and EHR challenges remain. Matthew Press, MD, explains how primary care can overcome these barriers and why integration is essential.
Raffi Tachdjian, MD, MPH, FAAAAI, FACAAI; Dareen D. Siri, MD, FAAAAI, FACAAI; Nicole Chase, MD, FAAP, FACAAI, FAAAAI; and Andrew White, MD, give final thoughts on asthma management, considering the current treatment landscape.
An expert discusses how the stage and diverse presentations of atopic dermatitis, especially in underserved and darker-skinned patients, influence treatment decisions, highlighting the promise of new nonsteroidal therapies and the importance of personalized, patient-centered care to improve quality of life.
Raffi Tachdjian, MD, MPH, FAAAAI, FACAAI; Dareen D. Siri, MD, FAAAAI, FACAAI; Nicole Chase, MD, FAAP, FACAAI, FAAAAI; and Andrew White, MD, give final thoughts on asthma management, considering the current treatment landscape.
Now that the WHO has declared a second mpox global emergency, you may want to brush up on knowledge of the disease and the 2024 outbreak.
ACOG 2025: Laxmi Gannu, MS, discusses key findings from a provider survey on postpartum depression screening practices, training gaps, and referral patterns.
Benjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Some states that are better for physicians than others in terms of finances, competition, and other criteria. Partner site Physicians Practice crunched the numbers for you.
How do low socioeconomic status and adverse childhood experiences tie into pediatric obesity? Here, an overview for practitioners.
Wade Brosius, DO, Shelton Hager, MD, and Steven Peskin, MD, answer questions relating to diabetic retinopathy screening devices and highlight novel technologies utilized in this space.
Panelists discuss how choosing topical treatments requires individualized therapy considering factors such as affected body areas, disease severity, patient age, formulation preferences, and insurance coverage.
Brexpiprazole and sertraline showed promise for PTSD treatment in a recent study. Lead author, Lori Davis, MD, discusses clinical findings, treatment guidelines, and future research directions.
When addressing mental health with patients with obesity, a thoughtful approach that balances psychological health and weight loss is critical, explains Dr Ethan Lazarus.
Experts wrap up their discussion of emerging chronic kidney disease tests and treatments with key takeaways for providers and patients.
The abrupt cancellation, without warning or cause, has medical groups and health care leaders concerned about patient access to no-cost preventive services.
Todd W. Frieze, MD, concludes this series discussing differences in benign vs cancerous tumors and key final takeaways.
Caissa Troutman, MD, shares 3 key strategies for managing hypertension in patients with obesity in primary care.
Collaboration among care team members is a key ingredient to effective support for children with disabilities and this specialist says her welcome mat is out for her neighbors.
To close this series, experts explore the challenges and guideline gaps in multi-cancer early detection while considering its potential impact on patient care, accessibility, and improved outcomes.
The FDA and CDC must adopt the VRBPAC recommendation before it can be considered for implementation.
The lead investigator of the largest clinical trial program in people with CAH discusses the condition, its burden, and the novel drug just approved that will change lives.
The panel of experts from UCSD concludes the discussion on delaying the onset of stage 3 T1D by providing key takeaways and clinical advice on the treatment of patients with this condition.
RAD 2025: Brad Glick, DO, MPH, discusses the intensity of TSW symptoms and cautions against assuming there is mental health disturbance at work.
Experts discuss key takeaways from the review article “Role of Bempedoic Acid in Clinical Practice”, clinical implications, and the greatly anticipated CLEAR Outcomes trial.
The CDC update recommends ending screening strategies that require multiple clinic visits for sample collection, favoring 1 visit and automatic HCV RNA testing.
Among the CDC vaccine advisory group's recommendations are adding COVID-19 vaccines to the Vaccine for Children program and allowing PCV20 shots for those who previously received PCV13.
Social determinants of health vary between patients living in different environments, so what are the key factors to consider when creating a treatment plan?
The “Do It For You & Them” campaign focuses on the impact that virus has on day-to-day lives.